RET and medullary thyroid gland carcinoma: <h4>Objective</h4>Sporadic medullary thyroid carcinoma (sMTC) is predominantly driven by somatic <i>RET</i> or <i>RAS</i> mutations, although the molecular basis of disease heterogeneity remains incompletely understood.